We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Senseonics Holdings (SENS) Flat As Market Sinks: What You Should Know
Read MoreHide Full Article
In the latest trading session, Senseonics Holdings (SENS - Free Report) closed at $3.05, marking no change from the previous day. This change was narrower than the S&P 500's daily loss of 0.54%.
Prior to today's trading, shares of the medical technology company had lost 12.86% over the past month. This has lagged the Medical sector's loss of 3.77% and the S&P 500's gain of 3.05% in that time.
SENS will be looking to display strength as it nears its next earnings release, which is expected to be August 9, 2021. Meanwhile, our latest consensus estimate is calling for revenue of $3 million, up 1052.69% from the prior-year quarter.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.72 per share and revenue of $14.02 million. These totals would mark changes of +6.49% and +182.68%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for SENS. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. SENS currently has a Zacks Rank of #3 (Hold).
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 222, putting it in the bottom 13% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Senseonics Holdings (SENS) Flat As Market Sinks: What You Should Know
In the latest trading session, Senseonics Holdings (SENS - Free Report) closed at $3.05, marking no change from the previous day. This change was narrower than the S&P 500's daily loss of 0.54%.
Prior to today's trading, shares of the medical technology company had lost 12.86% over the past month. This has lagged the Medical sector's loss of 3.77% and the S&P 500's gain of 3.05% in that time.
SENS will be looking to display strength as it nears its next earnings release, which is expected to be August 9, 2021. Meanwhile, our latest consensus estimate is calling for revenue of $3 million, up 1052.69% from the prior-year quarter.
Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.72 per share and revenue of $14.02 million. These totals would mark changes of +6.49% and +182.68%, respectively, from last year.
It is also important to note the recent changes to analyst estimates for SENS. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. SENS currently has a Zacks Rank of #3 (Hold).
The Medical Info Systems industry is part of the Medical sector. This group has a Zacks Industry Rank of 222, putting it in the bottom 13% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com.